No title available
ellievsbear
Monterey Bay Aquarium
occasionally subtle
PUT YOUR BEARD IN MY MOUTH
I'd rather be in outer space 🛸
One Nice Bug Per Day
cherry valley forever
Keni
JBB: An Artblog!
🪼
Janaina Medeiros
hello vonnie
Misplaced Lens Cap
Game of Thrones Daily
Kaledo Art
roma★
YOU ARE THE REASON
#extradirty
2025 on Tumblr: Trends That Defined the Year
seen from Türkiye
seen from United Kingdom
seen from United States
seen from T1
seen from Russia
seen from United States
seen from Germany
seen from Finland
seen from Sri Lanka
seen from South Korea
seen from United Kingdom
seen from France
seen from United Kingdom
seen from Singapore
seen from United Kingdom
seen from Malaysia
seen from United States
seen from United Kingdom
seen from Malaysia
seen from United States
@lou6807
Most Recent Changes to the IID Database | FDA
Most Recent Changes to the IID Database | FDA
Most Recent Changes to the Inactive Ingredient Database — Read on www.fda.gov/drugs/drug-approvals-and-databases/most-recent-changes-iid-database
View On WordPress
The History, Benefits of Pharmaceutical REMS Programs
The History, Benefits of Pharmaceutical REMS Programs
Some REMS programs may only require a medication guide to be distributed with each dispense that highlight safety information, such as relevant adverse events and risks associated with taking the product. — Read on www.pharmacytimes.com/
Great article to help understand the impact of adverse events reporting and how it is beneficial to public health to have programs like these.
View On WordPress
FDA approves first drug for treatment of peanut allergy for children
FDA approves first drug for treatment of peanut allergy for children
FDA approves first drug for treatment of peanut allergy for children — Read on s2027422842.t.en25.com/e/es
This is a huge achievement for all food allergy companies.
Looking forward to this rise of this market.
View On WordPress
FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer
FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer
FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer — Read on s2027422842.t.en25.com/e/es
View On WordPress
First Generic Drug Approvals | FDA
First Generic Drug Approvals | FDA
Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides the scientific and regulatory advice needed to bring safe, effective, high-quality generic alternatives to market, which in turn creates more affordable treatment options for patients. “First generics” are just what they sound like—the first approval by FDA which permits a…
View On WordPress
FDA In Brief: New analysis highlights link between generic drug competition and lower drug prices, underscores importance of FDA efforts to spur generic drug development and market entry
FDA In Brief: New analysis highlights link between generic drug competition and lower drug prices, underscores importance of FDA efforts to spur generic drug development and market entry
FDA In Brief: New analysis highlights link between generic drug competition and lower drug prices, underscores importance of FDA efforts to spur generic drug development and market entry — Read on s2027422842.t.en25.com/e/es
Don’t necessary agree with this approach…..
View On WordPress
FDA grants accelerated approval to first targeted treatment for rare Duchenne Muscular Dystrophy (DMD) mutation – Drug Information Update
FDA grants accelerated approval to first targeted treatment for rare Duchenne Muscular Dystrophy (DMD) mutation – Drug Information Update
FDA grants accelerated approval to first targeted treatment for rare Duchenne Muscular Dystrophy (DMD) mutation – Drug Information Update — Read on s2027422842.t.en25.com/e/es
View On WordPress
FDA Updates List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic
FDA Updates List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic
FDA Updates List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic — Read on s2027422842.t.en25.com/e/es
View On WordPress
NIH to investigate minor cannabinoids and terpenes for potential pain-relieving properties | NCCIH
NIH to investigate minor cannabinoids and terpenes for potential pain-relieving properties | NCCIH
This press release highlights new NCCIH research awards totaling approximately $3 million to investigate the potential pain-relieving properties and mechanisms of actions of phytochemicals in cannabis. — Read on nccih.nih.gov/news/press/09192019
View On WordPress
Targeting gut bacteria to treat alcoholic hepatitis | National Institutes of Health (NIH)
Targeting gut bacteria to treat alcoholic hepatitis | National Institutes of Health (NIH)
A therapy targeting bacteria that make a specific toxin lessened alcohol-associated liver disease in a mouse study. — Read on www.nih.gov/news-events/nih-research-matters/targeting-gut-bacteria-treat-alcoholic-hepatitis
View On WordPress
Channel in Nerve Cell May be Key in Unlocking Parkinson Disease Therapy
Channel in Nerve Cell May be Key in Unlocking Parkinson Disease Therapy
Researchers have identified a channel in nerve cells that may serve as a new approach to targeting Parkinson disease. — Read on www.pharmacytimes.com/
View On WordPress
Drug Trials Snapshots BRUKINSA | FDA
Drug Trials Snapshots BRUKINSA | FDA
Drug Trials Snapshots — Read on www.fda.gov/drugs/resources-information-approved-drugs/drug-trials-snapshots-brukinsa
More inhibitors for oncology.
View On WordPress
FDA Report: Changes in Marketplace Needed to Mitigate Drug Shortages
FDA Report: Changes in Marketplace Needed to Mitigate Drug Shortages
The FDA Drug Shortages Task Force addressed the root causes of drug shortages and proposed potential solutions. — Read on www.pharmacytimes.com/news/https//www.pharmacytimes.com/
View On WordPress
FDA Announces Availability of Draft Guidance – Type V DMFs for CDER-Led Combination Products Using Device Constituent Parts with Electronics or Software
FDA Announces Availability of Draft Guidance – Type V DMFs for CDER-Led Combination Products Using Device Constituent Parts with Electronics or Software
FDA Announces Availability of Draft Guidance – Type V DMFs for CDER-Led Combination Products Using Device Constituent Parts with Electronics or Software — Read on s2027422842.t.en25.com/e/es
View On WordPress
FDA approves new breakthrough therapy for cystic fibrosis | FDA
FDA approves new breakthrough therapy for cystic fibrosis | FDA
FDA approves breakthrough therapy Trikafta for patients 12 and older with cystic fibrosis who have at least one F508del mutation in the CFTR gene, estimated to represent 90% of the cystic fibrosis population. — Read on www.fda.gov/news-events/press-announcements/fda-approves-new-breakthrough-therapy-cystic-fibrosis
View On WordPress
Blocking Inflammatory Pathway May Stop Brain Metastasis from Melanoma
Blocking Inflammatory Pathway May Stop Brain Metastasis from Melanoma
Melanoma brain metastasis occurs when tumor cells hijack an inflammatory pathway in the brain and blocking this pathway could prevent metastasis from developing. Genetic tools inhibit the expression of the receptor on melanoma cells and block the ability of tumor cells to respond to astrocyte signaling and the development of brain metastases was inhibited. The findings suggest that blocking a…
View On WordPress
FDA Announces Availability of Draft Guidance – Drug Master Files
FDA Announces Availability of Draft Guidance – Drug Master Files
FDA Announces Availability of Draft Guidance – Drug Master Files — Read on s2027422842.t.en25.com/e/es
View On WordPress